Meds, Mind, Body & Benefits > Research News & Studies

Sumagen to Release Preliminary Trial Results


Western and Sumagen to release preliminary results from HIV/AIDS vaccine trials
By Communications Staff   
Monday, November 5, 2012
WHAT: Western University and Sumagen Canada will hold a briefing for media and London's research community regarding preliminary results for the first-ever human applied clinical study (SAV CT 01) of the world's only preventative HIV vaccine based on a genetically modified killed whole virus (SAV001-H), which was initiated in March 2012.
Last year, SAV001-H received approval by the United States Food and Drug Administration (FDA) to start human clinical trials.

WHEN: Tuesday, November 6, 2012 at 11 a.m.

WHERE: Siebens Drake Research Institute, Room 217, Western University, London, Ontario

WHO: Dr. Chil-Yong Kang of Western's Schulich School of Medicine & Dentistry and Dr. Dong Joon Kim of Sumagen Co. Ltd.

At this point no news means bad news?

Here is the link to the full story on the press release:

The short story is that "the initial results showed a significant increase in antibody production in participants, without causing any unusual responses to the volunteersí immune system."  and they are moving into phase 2 trials with 600 HIV negative, high risk, participants.

Another small, but important, step in the overall process.....



[0] Message Index

Go to full version